(R)-RuCl[(p-cymene)(BINAP)]Cl

(R)-RuCl[(p-cymene)(DM-SEGPHOS®)]Cl

(R)-RUCY™-XylBINAP

(R)-SDP

(R)-SEGPHOS®

(R)-SKBG-1

(R)-Tetrahydro-3-furoic acid

(R)-Timolol

(R)-Tol-BINAP

(R)-Tol-BINAP Pd G3

(R)-TolBINAP Pd G4

(R)-Tomoxetine hydrochloride

(R)-VANOL

(R)-VAPOL

(R)-Xyl-SDP(O)

(R)-ZINC-3573

(R)-[(RuCl(BINAP))₂(μ-Cl)₃[NH₂Me₂]

(R)-[(RuCl(SEGPHOS®))₂(μ-Cl)₃][NH₂Me₂]

(R)-[(RuCl(T-BINAP))₂(μ-Cl)₃[NH₂Me₂]

(R)-α,α-Bis[3,5-bis(trifluoromethyl)phenyl]-2-pyrrolidinemethanol trimethylsilyl ether

(R)-Α-(Fmoc-amino)-tetrahydro-2H-pyran-4-acetic acid

(R)-α-Acryloyloxy-β,β-dimethyl-γ-butyrolactone

(R)−RuCl[(p−cymene)(DM−BINAP)]Cl

(R)−RuCl[(p−cymene)(SEGPHOS®)]Cl

(R*)-2-((R*)-6,7-Dimethoxy-1,2,3,4-tetrahydro-isoquinolin-1-yl)-2-phenyl-ethanol

(R,R)-(+)-1,4-BIS-O-(4-CHLOROBENZYL)-D-THREITOL

(R,R)-(+)-1-(1-NAPHTHYL)-2-(2-NAPHTHYL)-1,2-ETHANEDIOL

(R,R)-(-)-1,2-BIS(2-CHLOROPHENYL)-1,2-ETHANEDIOL

(R,R)-(-)-Pseudoephedrine solution

(R,R)-(–)-2,3-Bis(tert-butylmethylphosphino)quinoxaline

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II)

(R,R)-(−)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride

(R,R)-(−)-N,N′-Dimethyl-1,2-cyclohexanediamine

(R,R)-2,2′-Bipyrrolidine ʟ-tartrate trihydrate

(R,R)-Bis-(2,4,6-trimethoxyphenyl)ethylenediamine dihydrochloride

(R,R)-Bis-(2-chlorophenyl)ethylenediamine dihydrochloride

(R,R)-Bis-(4-dimethylaminophenyl)ethylenediamine tetrahydrochloride

(R,R)-Bis-(4-fluorophenyl)ethylenediamine dihydrochloride

(R,R)-Bis-(4-methoxyphenyl)ethylenediamine dihydrochloride

(R,R)-DACH-naphthyl Trost ligand

(R,R)-DACH-phenyl Trost ligand

(R,R)-DIPAMP

(R,R)-Ms-DENEB™

(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminoaluminum chloride